The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.25
Bid: 20.50
Ask: 22.00
Change: 0.00 (0.00%)
Spread: 1.50 (7.317%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 21.25
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Non-Core Water Project Update

3 Feb 2014 07:00

RNS Number : 0691Z
Iofina PLC
03 February 2014
 



 

 

3 February 2014

 

Iofina plc.

("Iofina" or the "Group")

(LSE AIM: IOF)

 

Non-Core Water Project Update

 

Pursuant to the Group's statements issued on 13th and 23rd December 2013, Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, provides the market today with an update following its 30th January 2014 meeting with the Montana Department of Natural Resources and Conservation ("DNRC") regarding its review of the Group's non-core water rights application.The Board is pleased to announce that the DNRC has determined that the requested amount of water is both physically and legally available and that there would be no adverse effect at the point of diversion due to the engineering and design consideration outlined in the engineering study.The Board reports that Iofina has been granted up to 60 days from the meeting date to provide clarity to its addendum, presented at the meeting alongside revised letters of intent, and address any further questions from the DNRC accordingly. Once the final addendum and revised letters of intent have been completed and submitted to the DNRC, the State of Montana will either approve or deny the application. In the event of approval there is a 30 day notice period for a public hearing. In the event the application is denied the Group would request an immediate administrative hearing. The Board will update the market in due course.Commenting on today's news, Iofina's Chief Executive George Lantz commented:"The ongoing dialogue with the DNRC is encouraging and Iofina will continue to collaborate with the DNRC with the aim of achieving a successful outcome. The Board is confident in its ability to meet requests brought forth in its 30th January meeting as well as any further requests that may arise in the interim."

For further information, please contact:

 

George Lantz, CEO

Iofina plc

Tel: +44 (0) 20 3006 3135

www.iofina.com 

 

John Prior/Rupert Krefting/Huw Jeremy

Numis

Tel: +44(0)20 7260 1000

 

Rob Collins

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, Montana, and Oklahoma. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXAAELLLEFF
Date   Source Headline
8th Mar 20228:51 amRNSHolding(s) in Company
17th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSQ4 2021 Update
10th Jan 20227:00 amRNSHolding(s) in Company
10th Jan 20227:00 amRNSHolding(s) in Company
10th Jan 20227:00 amRNSHolding(s) in Company
29th Dec 20217:00 amRNSBusiness Update
20th Oct 202112:44 pmRNSHolding(s) in Company
15th Oct 20217:00 amRNSQ3 2021 Update
12th Oct 20218:47 amRNSHolding(s) in Company
24th Sep 20217:00 amRNSInterim Results
23rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:35 pmRNSPrice Monitoring Extension
22nd Sep 20219:58 amRNSHolding(s) in Company
10th Sep 20214:15 pmRNSHolding(s) in Company
10th Sep 20213:25 pmRNSHolding(s) in Company
15th Jul 20217:00 amRNSH1 2021 Update
18th Jun 20214:36 pmRNSPrice Monitoring Extension
18th Jun 20213:20 pmRNSResult of AGM
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:36 pmRNSPrice Monitoring Extension
27th May 20212:06 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
27th May 202111:06 amRNSSecond Price Monitoring Extn
27th May 202111:00 amRNSPrice Monitoring Extension
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSAnnual Financial Report
21st May 20215:50 pmRNSNotice of Results
15th Apr 20217:00 amRNSQ1 2021 Update
1st Mar 20215:36 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 20217:00 amRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSMarket Update
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:35 pmRNSPrice Monitoring Extension
22nd Dec 20202:05 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:00 pmRNSPrice Monitoring Extension
16th Dec 202011:50 amRNSGrant of Share Options
16th Oct 20207:00 amRNSQ3 2020 Update
13th Oct 20204:40 pmRNSSecond Price Monitoring Extn
13th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSINTERIM RESULTS
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:07 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:01 amRNSSecond Price Monitoring Extn
22nd Sep 20204:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
22nd Sep 20202:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.